Histopathological risk factors for malignancy in dermatomyositis

被引:5
|
作者
Pruessmann, Wiebke [1 ]
Kleinheinz, Andreas [2 ]
Zillikens, Detlef [1 ]
Rose, Christian [1 ,3 ]
机构
[1] Univ Lubeck, Dept Dermatol, Ratzeburger Allee 160, D-23538 Lubeck, Germany
[2] Dermatopathol Lubeck, Lubeck, Germany
[3] Clin Ctr Buxtehude, Dept Dermatol, Buxtehude, Germany
关键词
dermatomyositis; malignant neoplasms; histopathological risk factors; basement membrane thickening; pigment incontinence; CD123+plasmacytoid dendritic cells; eosinophils; PLASMACYTOID DENDRITIC CELLS; POLYMYOSITIS; EOSINOPHILS; DISTINCT;
D O I
10.1111/his.14727
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To identify possible histopathological risk factors for malignancy in skin biopsies of dermatomyositis patients. Methods and results: We analysed clinical metadata and studied 30 skin biopsies of 11 patients with and 12 patients without associated malignancy, who were treated in one secondary and one tertiary German medical centre between 2009 and 2022 and fulfilling the EULAR/ACR classification criteria for dermatomyositis. Specimens were categorized by malignancy status and evaluated based on haematoxylin and eosin (H&E), periodic acid Schiff (PAS), Alcian Blue, and anti-CD123 immunohistochemistry stains. After correcting for multiple testing, biopsies of patients with cancer exhibited more severe basement membrane thickening (P < 0.05) and pigment incontinence (P < 0.05) compared to patients without tumour burden. Patients with numerous subepidermal melanophages had a more than 5-times increased odds ratio to suffer from an internal malignancy (odds ratio [OR] 5.3, 95% confidence interval [CI] 1.3-54.2, P < 0.05). Furthermore, specimens of the malignancy group presented a distinct superficial distribution pattern of CD123+ plasmacytoid dendritic cells (PDCs, P < 0.01). Extravascular eosinophils were absent in all cases. Conclusion: Severity of basement membrane thickening, extent of pigment incontinence, and superficial distribution pattern of CD123+ PDCs could serve as useful histopathological indicators of risk for malignancy in dermatomyositis.
引用
收藏
页码:529 / 535
页数:7
相关论文
共 50 条
  • [1] Risk factors for malignancy in adult-onset dermatomyositis
    Bednar, E. D.
    Legault, K.
    Pavlova, V.
    Abu-Hilal, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : E122 - E124
  • [2] Clinical risk factors associated with malignancy in TIF1-γ(+) dermatomyositis
    Cassard, L.
    Flatley, E.
    Fernandez, A. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S27 - S27
  • [3] CLINICAL RISK FACTORS ASSOCIATED WITH MALIGNANCY IN TIF1-γ(+) DERMATOMYOSITIS PATIENTS
    Cassard, Lydia A.
    Flatley, Elizabeth M.
    Fernandez, Anthony P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 559 - 559
  • [4] Clinical and biological factors predictive of malignancy in dermatomyositis
    Prohic, A.
    Kasumagic-Halilovic, E.
    Simic, D.
    Selmanagic, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (05) : 591 - 592
  • [5] Autoantibodies and malignancy risk in patients with vesiculobullous dermatomyositis
    Breedveld, Sophie
    Prenner, Joshua
    Zhao, Grant
    Shastry, Jennifer L.
    Nguyen, Cuong, V
    RHEUMATOLOGY, 2025,
  • [6] Polymyositis/dermatomyositis and Malignancy Risk: A Metaanalysis Study
    Yang, Zaixing
    Lin, Feng
    Qin, Baodong
    Liang, Yan
    Zhong, Renqian
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (02) : 282 - 291
  • [7] Prognosis factors and predictive signs of malignancy in dermatomyositis.
    Gallais, V
    Crickx, B
    Belaich, S
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1996, 123 (11): : 722 - 726
  • [8] Dermatomyositis and malignancy
    Selvaag, E
    Austad, J
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1996, 21 (06) : 463 - 464
  • [9] DERMATOMYOSITIS AND MALIGNANCY
    VESTERAGER, L
    WORM, AM
    THOMSEN, K
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1980, 5 (01) : 31 - 35
  • [10] Dermatomyositis and malignancy
    Hu, Tina
    Vinik, Ophir
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (06) : 409 - 411